Free Trial
NASDAQ:IVF

INVO Fertility Q3 2023 Earnings Report

INVO Fertility logo
$0.96 +0.01 (+0.88%)
As of 08/29/2025 04:00 PM Eastern

INVO Fertility EPS Results

Actual EPS
-$25.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

INVO Fertility Revenue Results

Actual Revenue
$0.98 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

INVO Fertility Announcement Details

Quarter
Q3 2023
Time
N/A
Conference Call Date
Monday, November 13, 2023
Conference Call Time
4:00PM ET

Earnings Documents

INVO Fertility Earnings Headlines

INVO Fertility (NASDAQ:IVF) Trading Down 22% - Here's Why
New Banking Law #1582 Could Unlock $21 Trillion for Americans
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
INVO Fertility’s Recent Unregistered Equity Sale
See More INVO Fertility Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like INVO Fertility? Sign up for Earnings360's daily newsletter to receive timely earnings updates on INVO Fertility and other key companies, straight to your email.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

View INVO Fertility Profile

More Earnings Resources from MarketBeat